CT based 3D printing is superior to transesophageal echocardiography for pre-procedure planning in left atrial appendage device closure.

Autor: Obasare E; Einstein Heart and Vascular Institute, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA. ObasareE@einstein.edu.; Einstein Medical Center, 5501 Old York Road, Room 3232 Levy Building, Philadelphia, PA, 19141, USA. ObasareE@einstein.edu., Mainigi SK; Einstein Heart and Vascular Institute, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA., Morris DL; Einstein Heart and Vascular Institute, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA., Slipczuk L; Einstein Heart and Vascular Institute, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA., Goykhman I; Department of Radiology, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA., Friend E; Einstein Heart and Vascular Institute, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA., Ziccardi MR; Department of Internal Medicine, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA., Pressman GS; Einstein Heart and Vascular Institute, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA, 19141, USA.
Jazyk: angličtina
Zdroj: The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2018 May; Vol. 34 (5), pp. 821-831. Date of Electronic Publication: 2017 Dec 08.
DOI: 10.1007/s10554-017-1289-6
Abstrakt: Accurate assessment of the left atrial appendage (LAA) is important for pre-procedure planning when utilizing device closure for stroke reduction. Sizing is traditionally done with transesophageal echocardiography (TEE) but this is not always precise. Three-dimensional (3D) printing of the LAA may be more accurate. 24 patients underwent Watchman device (WD) implantation (71 ± 11 years, 42% female). All had complete 2-dimensional TEE. Fourteen also had cardiac computed tomography (CCT) with 3D printing to produce a latex model of the LAA for pre-procedure planning. Device implantation was unsuccessful in 2 cases (one with and one without a 3D model). The model correlated perfectly with implanted device size (R 2  = 1; p < 0.001), while TEE-predicted size showed inferior correlation (R 2  = 0.34; 95% CI 0.23-0.98, p = 0.03). Fisher's exact test showed the model better predicted final WD size than TEE (100 vs. 60%, p = 0.02). Use of the model was associated with reduced procedure time (70 ± 20 vs. 107 ± 53 min, p = 0.03), anesthesia time (134 ± 31 vs. 182 ± 61 min, p = 0.03), and fluoroscopy time (11 ± 4 vs. 20 ± 13 min, p = 0.02). Absence of peri-device leak was also more likely when the model was used (92 vs. 56%, p = 0.04). There were trends towards reduced trans-septal puncture to catheter removal time (50 ± 20 vs. 73 ± 36 min, p = 0.07), number of device deployments (1.3 ± 0.5 vs. 2.0 ± 1.2, p = 0.08), and number of devices used (1.3 ± 0.5 vs. 1.9 ± 0.9, p = 0.07). Patient specific models of the LAA improve precision in closure device sizing. Use of the printed model allowed rapid and intuitive location of the best landing zone for the device.
Databáze: MEDLINE